2018
DOI: 10.1182/blood-2017-05-787226
|View full text |Cite
|
Sign up to set email alerts
|

Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells

Abstract: Eradication of chemotherapy-resistant leukemia stem cells is expected to improve treatment outcomes in patients with acute myelogenous leukemia (AML). In a mouse model of AML expressing the fusion, we found that Ring1A and Ring1B, components of Polycomb repressive complex 1, play crucial roles in maintaining AML stem cells. Deletion of and (/) from AML cells diminished self-renewal capacity and induced the expression of numerous genes, including Overexpression of caused AML cells to differentiate into mature c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(22 citation statements)
references
References 52 publications
0
20
0
1
Order By: Relevance
“…131 Also, in stem cells of acute myelogenous leukemia, Ring1 maintains the stemness of the cancer cells. 132…”
Section: Epigenetics Of Stemness and Quiescencementioning
confidence: 99%
“…131 Also, in stem cells of acute myelogenous leukemia, Ring1 maintains the stemness of the cancer cells. 132…”
Section: Epigenetics Of Stemness and Quiescencementioning
confidence: 99%
“…Here, we constructed a PPI network using nine colon CSC markers and discovered a cluster of significant targets. Most of these genes were related to CSCs, such as CD63 [45], MCM2 [46], CAV1 [47], GLIS2 [48], CDC20 [49,50], LATS2 [51] and FGF2 [52,53]. Interestingly, TMEM17, being the marker with the second highest resampling frequency in the survival analysis, has not been reported as marker of CSCs yet and its pathological function in other tumors has been found to be contradicted [19,20].…”
Section: Discussionmentioning
confidence: 99%
“…30,31 A recent study reported that Glis2 promotes differentiation of AML stem cells in mice. 32 These results suggest that a change in GLIS2 regulation induces abnormal cell proliferation, leading to a risk of MM. We also found that the variants linked with the risks of most traits, specifically systemic sclerosis, were strongly enriched in binding motifs of EGR factors (EGR2, EGR3, and EGR4).…”
Section: Resultsmentioning
confidence: 88%